Stocks
Vaxxinity, Inc.VAXX
PNKHealthcareBiotechnology$0.00-99.00%
Price as of · delayed, not real-time
Focused on developing synthetic peptide vaccines for chronic diseases and infectious diseases, this clinical-stage biotechnology company aims to disrupt traditional vaccine approaches. Investors monitor VAXX for its potential to address large markets like Alzheimer's and COVID-19 with potentially cheaper, more stable vaccine candidates.
Market Cap: $12,67852W Range: $0.00 – $0.20
Congressional Interest in Vaxxinity, Inc. (VAXX)
1 member of Congress has disclosed 1 trade in Vaxxinity, Inc. (VAXX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading VAXX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-12-20 | Rick Scott | sell | $1K – $15K |